Bhagiradha Chemicals Reports Q3FY26 Results, Announces CFO Transition

3 min read     Updated on 10 Feb 2026, 04:00 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Bhagiradha Chemicals & Industries Limited reported Q3FY26 standalone revenue of ₹11,392.19 lakhs with net profit of ₹482.79 lakhs, while consolidated revenue reached ₹11,397.18 lakhs with net profit of ₹461.58 lakhs. The company announced the retirement of CFO B. Krishna Mohan Rao effective February 28, 2026, and appointed Ranjit Kumar Kilaru, a Chartered Accountant with over 23 years of experience, as the new CFO from March 1, 2026. Nine-month performance showed revenue growth of 18.59% on standalone basis to ₹37,206.04 lakhs, though net profit declined to ₹1,903.04 lakhs.

32265055

*this image is generated using AI for illustrative purposes only.

Bhagiradha Chemicals & Industries Limited has announced its unaudited financial results for the quarter ended December 31, 2025, along with significant changes in key managerial personnel. The Board of Directors approved these developments during their meeting held on February 10, 2026.

Financial Performance for Q3FY26

The company delivered mixed performance across its standalone and consolidated operations during the third quarter of fiscal year 2026.

Standalone Results

Metric Q3FY26 Q3FY25 Change
Revenue from Operations ₹11,392.19 lakhs ₹10,273.13 lakhs +10.89%
Net Profit ₹482.79 lakhs ₹712.98 lakhs -32.29%
Basic EPS (Annualised) ₹0.37 ₹0.57 -35.09%
Diluted EPS (Annualised) ₹0.37 ₹0.53 -30.19%

Consolidated Results

Metric Q3FY26 Q3FY25 Change
Revenue from Operations ₹11,397.18 lakhs ₹10,273.13 lakhs +10.94%
Net Profit ₹461.58 lakhs ₹359.41 lakhs +28.43%
Basic EPS (Annualised) ₹0.36 ₹0.28 +28.57%
Diluted EPS (Annualised) ₹0.36 ₹0.26 +38.46%

Nine-Month Performance Overview

For the nine months ended December 31, 2025, the company showed varied performance trends between standalone and consolidated operations.

Nine-Month Standalone Performance

Parameter 9M FY26 9M FY25 Change
Revenue from Operations ₹37,206.04 lakhs ₹31,372.47 lakhs +18.59%
Net Profit ₹1,903.04 lakhs ₹2,222.83 lakhs -14.38%
Basic EPS ₹1.47 ₹1.84 -20.11%

Nine-Month Consolidated Performance

Parameter 9M FY26 9M FY25 Change
Revenue from Operations ₹37,784.68 lakhs ₹31,785.20 lakhs +18.88%
Net Profit ₹1,409.92 lakhs ₹1,474.15 lakhs -4.36%
Basic EPS ₹1.09 ₹1.22 -10.66%

Leadership Transition in CFO Role

The company announced significant changes in its key managerial personnel structure. B. Krishna Mohan Rao will retire from his position as Chief Financial Officer and Key Managerial Personnel effective from the close of business hours on February 28, 2026. The Board placed on record their appreciation for his valuable contribution and guidance during his association with the company.

New CFO Appointment

Detail Information
New CFO Mr. Ranjit Kumar Kilaru
Effective Date March 01, 2026
Designation Chief Financial Officer and Key Managerial Personnel
Qualification Chartered Accountant
Experience Over 23 years post-qualification

Ranjit Kumar Kilaru brings extensive experience across banking, manufacturing, and financial advisory services. He has been working as a consultant in financial planning and debt syndication for the past four years. His banking experience spans over 17 years, including more than 13 years with Axis Bank Limited in various functional roles, where he served as Deputy Vice President and Centre Head – SME, Hyderabad.

Updated Key Managerial Personnel

Following the leadership changes, the company's Key Managerial Personnel from March 01, 2026, will include:

  • S. Chandra Sekhar - Managing Director
  • A. Arvind Kumar - Executive Director and Chief Executive Officer
  • Ranjit Kumar Kilaru - Chief Financial Officer
  • Sharanya. M - Company Secretary and Compliance Officer

Business and Regulatory Notes

The company operates primarily in the agrochemicals segment as its single reportable business segment. Both standalone and consolidated financial results have been prepared in accordance with Indian Accounting Standards (Ind-AS) and reviewed by the Audit Committee before Board approval. The statutory auditors have expressed an unmodified opinion on these unaudited results.

The company has adopted the concessional corporate tax rate of 22% with effect from April 1, 2025, pursuant to the Taxation Laws (Amendment) Ordinance, 2019. The consolidated results include the parent company and its wholly owned subsidiary, Bheema Fine Chemicals Private Limited.

Historical Stock Returns for Bhagiradha Chemicals & Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-0.88%-4.30%-3.99%-27.77%-30.93%-71.96%
Bhagiradha Chemicals & Industries
View Company Insights
View All News
like20
dislike

Bhagiradha Chemicals & Industries Limited Schedules Board Meeting for February 10, 2026 to Consider Q3FY26 Financial Results

1 min read     Updated on 30 Jan 2026, 01:10 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Bhagiradha Chemicals & Industries Limited has scheduled a board meeting for February 10, 2026, to consider Q3FY26 unaudited financial results for the quarter and nine months ended December 31, 2025. The meeting will review both standalone and consolidated results along with the statutory auditors' limited review report. The company has implemented a trading window closure from January 01, 2026, until 48 hours after the financial results declaration, applicable to all designated persons and their immediate relatives in compliance with SEBI insider trading regulations.

31304422

*this image is generated using AI for illustrative purposes only.

Bhagiradha chemicals & industries Limited has announced a board meeting scheduled for February 10, 2026, to consider and approve the company's unaudited financial results for the third quarter of fiscal year 2026. The meeting will be held at the company's Hyderabad office to transact important business items as per the regulatory requirements.

Board Meeting Agenda

The board meeting has been convened in accordance with Regulation 29, 33 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting agenda includes two primary items for consideration:

Agenda Item: Details
Financial Results Review: Un-Audited Financial Results (Standalone & Consolidated) for Quarter/Nine months ended December 31, 2025
Auditor's Report: Limited Review Report of Statutory Auditors on Un-Audited Financial Results (Standalone & Consolidated) for Quarter/Nine months ended December 31, 2025

Trading Window Closure

In compliance with regulatory requirements, the company has implemented a trading window closure for all designated persons and their immediate relatives. The restrictions are effective under the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal Code of Conduct for prevention of insider trading.

Parameter: Details
Closure Period: January 01, 2026 till 48 hours after financial results declaration
Applicable To: All designated persons and their immediate relatives
Securities Covered: Equity shares of the company

Regulatory Compliance

The company has formally notified both BSE Limited and National Stock Exchange of India Limited about the scheduled board meeting through official communication dated January 30, 2026. The notification was signed by Sharanya M, Company Secretary & Compliance Officer, ensuring proper adherence to stock exchange listing requirements.

The meeting represents a standard quarterly review process where the board will evaluate the company's financial performance for the third quarter and nine-month period ending December 31, 2025. The results will provide stakeholders with insights into the company's operational and financial performance during this period.

Historical Stock Returns for Bhagiradha Chemicals & Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-0.88%-4.30%-3.99%-27.77%-30.93%-71.96%
Bhagiradha Chemicals & Industries
View Company Insights
View All News
like18
dislike

More News on Bhagiradha Chemicals & Industries

1 Year Returns:-30.93%